Wintac is currently trading at Rs. 204.00, up by 1.25 points or 0.62% from its previous closing of Rs. 202.75 on the BSE.
The scrip opened at Rs. 203.30 and has touched a high and low of Rs. 206.95 and Rs. 203.30 respectively. So far 214 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 239.30 on 22-Mar-2019 and a 52 week low of Rs. 166.00 on 04-Feb-2019.
Last one week high and low of the scrip stood at Rs. 209.00 and Rs. 200.00 respectively. The current market cap of the company is Rs. 203.79 crore.
The promoters holding in the company stood at 54.99%, while Institutions and Non-Institutions held 0.01% and 45.00% respectively.
Wintac is planning to raise fund up to Rs 135 crore through External Commercial Borrowings (ECB) for repayment of existing bank borrowings and to meeting working capital and CAPEX requirements. The Board of Directors of the Company at its meeting to be held on April 11, 2019 to consider the same.
Wintac is a professionally managed and fully integrated pharmaceutical company that is committed in developing, manufacturing and marketing of high quality pharmaceutical formulations using innovative technologies and meeting the cGMP standards which are continuously updated to international requirements.
